Clinical Trial Update: A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial investigating intravenous human normal immunoglobulin 10% for adults with Stiff Person Syndrome is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stiff-person Syndrome

Drugs mentioned

• intravenous human normal immunoglobulin 10%

Snippet

Sponsor: Kedrion S.p.A. | Conditions: Stiff Person Syndrome | Phase 3 | Status: NOT_YET_RECRUITING